Vitamin D for Prediabetes

(D2d-TTT Trial)

This trial explores whether vitamin D can help control blood sugar in individuals with prediabetes, a condition where blood sugar is elevated but not yet classified as diabetes. Participants will take either a vitamin D supplement (cholecalciferol) or a placebo weekly for about 18 months. The primary goal is to determine if the vitamin D group achieves better blood sugar control than the placebo group. The trial seeks adults diagnosed with prediabetes who may struggle to maintain steady blood sugar levels. As a Phase 3 trial, it represents the final step before FDA approval, offering participants an opportunity to contribute to potentially groundbreaking treatment advancements.

You may need to stop certain medications to join the trial. If you are using medications for diabetes, weight management, or high doses of vitamin D or calcium supplements, you might need to stop or adjust them. It's best to discuss your specific medications with the research team.

Research has shown that vitamin D is generally safe and well-tolerated. Studies have found that a high dose of vitamin D (4,000 IU per day) was safe for individuals who are overweight or obese and at high risk for diabetes. Even at higher doses, vitamin D did not cause major side effects in these groups. The evidence suggests that vitamin D is unlikely to cause harm when used in a clinical trial for prediabetes.¹²³⁴⁵

Unlike the standard treatments for prediabetes, which typically include lifestyle changes and medications like metformin, vitamin D (cholecalciferol) offers a unique approach. Researchers are excited about vitamin D because it potentially addresses insulin sensitivity through a different mechanism, possibly enhancing the body's natural ability to manage blood sugar levels. Additionally, vitamin D is a widely available and easily administered supplement, which could make it an accessible option for many individuals. If effective, it could offer a simple, non-invasive addition to current prediabetes management strategies.

Research has shown that vitamin D can help control blood sugar levels in people with prediabetes. Studies have found that taking vitamin D lowers the risk of developing type 2 diabetes by about 15%. Some studies also report that vitamin D improves how well the body uses insulin. A meta-analysis, which combines results from several studies, confirmed that vitamin D reduces the chances of getting diabetes in people with prediabetes. Overall, the evidence suggests that vitamin D might be a useful way to lower diabetes risk for those at high risk. Participants in this trial will receive either vitamin D or a placebo to evaluate its effectiveness in reducing diabetes risk.¹³⁶⁷⁸